XML 42 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Operating Activities:      
Net (loss) earnings $ (310.5) $ 1,062.7 $ 1,687.5
Adjustments to reconcile net (loss) earnings to net cash provided by (used in) operating activities:      
Depreciation and amortization of property, plant and equipment 432.4 369.7 374.0
Amortization of intangibles 192.7 202.5 203.1
Inventory step-up amortization 0.0 80.3 20.7
Loss on sales of businesses 10.8 8.4 0.6
Gain on equity method investment 0.0 0.0 (68.0)
Gain (loss) on sale of discontinued operations 14.3 (1,197.4) 0.0
Asset impairment charges 274.8 168.4 0.0
Craftsman contingent consideration remeasurement from MTD acquisition 0.0 0.0 101.1
Stock-based compensation expense 83.8 90.7 118.3
Provision for credit losses 8.7 30.0 18.7
Share of net earnings of equity method investment 0.0 0.0 (19.0)
Deferred tax benefit (424.3) (271.7) (386.9)
Other non-cash items 154.5 72.1 27.7
Changes in operating assets and liabilities:      
Accounts receivable (117.0) 109.0 (280.6)
Inventories 906.6 (792.4) (1,970.4)
Accounts payable (23.0) (991.4) 758.3
Deferred revenue 2.4 (29.9) 1.9
Other current assets 115.6 15.6 (166.8)
Other long-term assets (175.7) (351.3) (438.8)
Accrued expenses (25.6) (176.3) 444.0
Defined benefit liabilities (42.2) (31.9) (40.0)
Other long-term liabilities 113.0 173.4 277.7
Net cash provided by (used in) operating activities 1,191.3 (1,459.5) 663.1
Investing Activities:      
Capital and software expenditures (338.7) (530.4) (519.1)
Sales of assets 15.1 41.7 8.4
Business acquisitions, net of cash acquired 0.0 (71.9) (2,043.8)
Sales of businesses, net of cash sold (5.7) 4,147.1 5.3
Net investment hedge settlements 0.0 10.6 (55.1)
Other 1.6 (24.5) (19.5)
Net cash (used in) provided by investing activities (327.7) 3,572.6 (2,623.8)
Financing Activities:      
Payments on long-term debt 0.0 0.0 (1.5)
Proceeds from debt issuances, net of fees 745.3 992.6 0.0
Net short-term commercial paper (repayments) borrowings (1,044.7) (138.1) 2,224.6
Stock purchase contract fees 0.0 (39.4) (39.4)
Credit facility borrowings 0.0 2,500.0 0.0
Credit facility repayments 0.0 (2,500.0) 0.0
Purchases of common stock for treasury (16.1) (2,323.0) (34.3)
Proceeds from issuance of remarketed preferred stock 0.0 750.0 0.0
Redemption and conversion of preferred stock 0.0 (750.0) (750.0)
Proceeds from issuances of common stock 19.0 38.7 131.4
Craftsman contingent consideration payments (18.0) (41.3) (29.3)
Termination of interest rate swaps 0.0 22.7 (75.3)
Cash dividends on common stock (482.6) (465.8) (474.8)
Cash dividends on preferred stock 0.0 (5.8) (18.9)
Other (18.9) (11.7) (13.8)
Net cash (used in) provided by financing activities (816.0) (1,971.1) 918.7
Effect of exchange rate changes on cash and cash equivalents 2.1 (31.9) (61.5)
Change in cash, cash equivalents and restricted cash 49.7 110.1 (1,103.5)
Cash, cash equivalents and restricted cash, beginning of year 404.9 294.8 1,398.3
Cash, cash equivalents and restricted cash, end of year 454.6 404.9 294.8
Supplemental Cash Flow Information [Abstract]      
Cash and cash equivalents 449.4 395.6  
Restricted cash included in Other current assets 4.6 9.3  
Cash and cash equivalents included in Current assets held for sale 0.6 0.0  
Cash, cash equivalents and restricted cash $ 454.6 $ 404.9 $ 294.8